NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy - Wikidata - wikimedia - TriplyDB

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

http://www.wikidata.org/entity/Q28289929

about

Multiple system atrophy: cellular and molecular pathology.Multiple system atrophy: a clinical and neuropathological perspective Glia and alpha-synuclein in neurodegeneration: A complex interaction Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channel Widespread alterations of alpha-synuclein in multiple system atrophy The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Alpha-synuclein in Lewy body disease and Alzheimer's disease.Multiple system atrophy: a sporadic synucleinopathy.Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia Neuropathology of synuclein aggregates.Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.Late-onset neurodegenerative diseases--the role of protein insolubility.The pathogenesis of multiple system atrophy: past, present, and future.Encephalomyelitis, brain tumors, neuromuscular diseases and miscellaneous disorders.β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.The cellular pathology of Parkinson's disease.Glial cell inclusions and the pathogenesis of neurodegenerative diseases Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.Iron in neurodegenerative disorders.SIRT1 protects against α-synuclein aggregation by activating molecular chaperones Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques Cellular pathology in multiple system atrophy.Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.Multiple system atrophy: alpha-synuclein and neuronal degeneration.The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins Neuropathology underlying clinical variability in patients with synucleinopathies.The Lewy body in Parkinson's disease and related neurodegenerative disorders.Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?Multiple system atrophy of the cerebellar type: clinical state of the art.α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.An update on the cerebellar subtype of multiple system atrophy.Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction

P2860

Q24535446-AF9ED9C3-2AB5-404D-A279-4AB7DAC92D26 Q26829838-A238E8C5-36CF-417B-B88F-A244D0EB79B8 Q26851153-B6132BD5-DBD5-499E-9AD2-2FA29EF083F9 Q28079379-2512C843-43DC-4A0C-BD87-8A5627BE5F49 Q30153436-67CAE1FA-EFB8-44AB-8C31-BBE4FECCD1F8 Q30444927-C9895AED-270F-41F2-81E0-0373B02E95F3 Q31807516-559103DE-ACE7-4970-BF34-141570A85669 Q33703950-052895D1-FC3C-4018-8FD8-8A5E32ED5E0E Q33750063-D72F4EE4-5B92-4E55-AC03-29C9B23FBFA2 Q33750069-5BDAFD8C-F0A8-4FF4-B705-6590FE451695 Q33805560-D15E7D3F-C7EC-48A2-936C-8086A31D10A0 Q33821143-E7B6AE79-3F1C-47DE-8727-051B7E6CE6B7 Q33957376-41D55809-4CC1-4753-B92D-54066081AB00 Q33958289-192E20F9-8875-4BCD-92CA-E3CA226CB6BE Q33989372-66D3070A-649E-4186-A5B7-8199D287BFBE Q34048136-34F0FF5C-1CF0-4BAF-8E6C-19CF557C627D Q34063829-A093FF42-643F-46DA-BE1E-72B2B5570302 Q34107278-9C2A7456-3455-4A1F-BE1C-74A4073258CF Q34233323-828E71F9-6368-4977-BEF9-B56BD96AFCCB Q34523836-896BB217-BF00-41D6-ABD5-AF13EE2593D9 Q34538330-1AD0FF78-0B84-43BD-BC04-7F8F7D9EB962 Q34648491-B81E5901-967E-4A09-9DFC-8CD007620411 Q35112542-699682C2-2275-4628-A65E-8F1AFBF9B6DD Q35686386-39103561-F243-4611-8F51-5FDE9E3951C5 Q35788235-52A1BA6B-C8F3-467B-B42F-0100AADCC15D Q35829548-440882E0-A392-4E68-902F-7844EDDE58EC Q36197708-848FB3B1-7F3E-4197-8B47-6F7F56B8909D Q36589164-E3DD7B40-78AF-49E0-A9D2-EA564E42EC61 Q36788234-F01E3370-7DDC-4453-BEF5-AF9BDD58DD6D Q37003479-75A43F62-3FBB-4E50-8842-0F83D026E0B9 Q37003482-794AAA4B-5C6E-431C-AFB4-96DBC9E08DEE Q37164569-A2424F31-98EE-4C1B-9D26-799C52B3F0DE Q37401787-F62145B6-2585-4681-8923-9A26AC7AE794 Q37896515-A94CB946-DBAE-41C3-B4B8-0B36D120E11B Q38012653-3383DC3E-71CC-437F-BA88-2470F095AE70 Q38067885-B881BB5E-C1CE-4182-A3C0-001318DEB085 Q38194974-DB76A960-27B4-4A8E-B0B5-02D0A050DD88 Q38241438-D68E9A87-6900-4A88-819C-C59434B0F554 Q38578814-E9EE8659-2DA7-45B4-A0EB-D867B4A5B3BB Q38923732-68C6C0CC-8DCC-4D8D-A87B-4251D4A91272

P2860

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

http://www.wikidata.org/entity/Q28289929

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@ast

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@en

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@nl

type

label

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@ast

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@en

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@nl

prefLabel

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@ast

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@en

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@nl

P1433

Q28289929-967B337E-859E-4E13-A14B-8FD95F0345E4

P1476

Q28289929-7B8EE195-0F7B-4DEE-A543-F03D58D454AF

P2093

Q28289929-5492F2B0-94AE-42F1-B304-33E4995F9FDF

Q28289929-B57845AC-103E-43F2-AE33-53C5F5C631BD

Q28289929-B72C0B0A-2888-4B94-95C3-C87DB1FF1D98

Q28289929-CEA00C2B-6B15-4B03-BC5D-51BD7BCEAA9A

Q28289929-E0C208A5-CC4E-4DA9-A8BF-71D3448CCD88

Q28289929-EFE8578D-8DB3-4BB4-B4D5-2EFACE15DEAE

Q28289929-F378A223-A2AF-45C9-A0AF-B4F601BE5993

Q28289929-FBF5D605-732C-4859-BA67-FD02C37D83CB

P2888

Q28289929-81B41B58-C208-45B7-B4D9-77121EAE0668

P304

Q28289929-CAF666D8-7532-4752-8B03-475ADDBBDEC2

P31

Q28289929-7962FA85-7F91-4455-BF3C-28AF2CA8A031

P356

Q28289929-AEBA5966-3E82-4B50-99BF-9B37A056BCAB

P407

Q28289929-682E9283-DB24-4E6B-BA9B-C8C459DC2814

P433

Q28289929-52CA1856-0A70-4AB9-A030-13F1E1964C52

P478

Q28289929-D51CE866-F1D0-4210-BE60-C5EE0AA5D9AC

P577

Q28289929-D9507988-15EA-4E64-A095-6009248F0DCE

P5875

Q28289929-380F1B12-C702-47C5-A86E-542D50056D86

P6179

Q28289929-0218D6D1-8939-4A77-99BE-DE3D83A142CB

P698

Q28289929-716C0CE9-EBE5-486A-840D-4BD90394F68C

P921

Q28289929-86A3B6A5-C90F-4576-B369-ABA8B198F7A8

Q28289929-CCB33855-7DE4-4FA6-BA14-2E47652460FC

P356

P1433

Acta Neuropathologica

P1476

NACP/alpha-synuclein immunorea ...... lei in multiple system atrophy

@en

P2093

H Tonozuka-Uehara

http://www.w3.org/2001/XMLSchema#string

K Arakawa

http://www.w3.org/2001/XMLSchema#string

K Arima

http://www.w3.org/2001/XMLSchema#string

K Uéda

http://www.w3.org/2001/XMLSchema#string

M Kawai

http://www.w3.org/2001/XMLSchema#string

M Nakamura

http://www.w3.org/2001/XMLSchema#string

N Sunohara

http://www.w3.org/2001/XMLSchema#string

S Hirai

http://www.w3.org/2001/XMLSchema#string

P2888

P304

439-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S004010050917

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13456566

http://www.w3.org/2001/XMLSchema#string

P6179

1015249478

http://www.w3.org/2001/XMLSchema#string

P698

9829806

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte